Get in Touch

Commercial Enterprises

Investment in commercial enterprises and management — retail operations, trading entities, logistics platforms, and service-oriented businesses.

01

Overview

The commercial sector represents one of Epiidosis's most active license activities. Under DED License No. 896592, we are authorised to invest in, establish, and manage commercial enterprises across all operating jurisdictions.

Our commercial portfolio focuses on businesses with recurring revenue models, defensible market positions, and operational scalability. We look for enterprises where disciplined management and capital deployment can create compounding long-term value.

02

Focus Areas

Retail Operations

Consumer-facing retail businesses across food, fashion, lifestyle, and specialty categories in high-traffic locations.

Trading & Logistics

Import/export trading entities and logistics platforms serving cross-border commerce between our operating jurisdictions.

Professional Services

Service-oriented businesses in consulting, technology services, and business process management.

Commercial Real Estate

Investment in commercial properties — office spaces, retail units, and mixed-use developments across strategic locations.

03

Jurisdictions

UAE — Primary market for commercial operations
India — Growing consumer market with 1.4B+ population
Kenya — East Africa's largest commercial hub (prospective)

Exploring Sector Alignment?

We welcome structured dialogue with qualified counterparties aligned with our licensed sector focus and governance standards.

Epiidosis Investments L.L.C (DED Commercial License No. 896592, Register No. 1982638, DCCI No. 341676) operates solely as a principal investor, enterprise owner, and project operator under its Dubai Department of Economy and Tourism mainland commercial license. The company is licensed exclusively for investment in, establishment of, and management of enterprises across commercial, industrial, agricultural, tourism, energy, healthcare, education, and oil & gas sectors.

All materials on this website are informational and intended for qualified counterparties coordinating private operating mandates. This website does not constitute an offer, solicitation, or advertisement for any securities, financial products, or regulated services. Epiidosis does not solicit public investment, manage third-party capital, provide investment advisory or brokerage services, or conduct any activity requiring SCA, DFSA, or FSRA authorization.

Any engagement requires bilateral non-disclosure agreements, compliance clearance, and confirmation that accessing this content is lawful in the relevant jurisdiction.